Literature DB >> 22294695

Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages.

Jana Zeitvogel1, Alexander Dalpke, Britta Eiz-Vesper, Michael Kracht, Oliver Dittrich-Breiholz, Thomas Werfel, Miriam Wittmann.   

Abstract

Suppressor of cytokine signaling (SOCS)3 belongs to a family of proteins that are known to exert important functions as inducible feedback inhibitors and are crucial for the balance of immune responses. There is evidence for a deregulated immune response in chronic inflammatory skin diseases. Thus, it was the aim of this study to investigate the regulation of SOCS proteins involved in intracellular signaling pathways occurring during inflammatory skin diseases and analyze their impact on the course of inflammatory responses. Because we and others have previously described that the cytokine IL-27 has an important impact on the chronic manifestation of inflammatory skin diseases, we focused here on the signaling induced by IL-27 in human primary keratinocytes compared with autologous blood-derived macrophages. Here, we demonstrate that SOCS3 is critically involved in regulating the cell-specific response to IL-27. SOCS3 was found to be significantly up-regulated by IL-27 in macrophages but not in keratinocytes. Other STAT3-activating cytokines investigated, including IL-6, IL-22, and oncostatin M, also failed to up-regulate SOCS3 in keratinocytes. Lack of SOCS3 up-regulation in skin epithelial cells was accompanied by prolonged STAT1 and STAT3 phosphorylation and enhanced CXCL10 production upon IL-27 stimulation compared with macrophages. Overexpression of SOCS3 in keratinocytes significantly diminished this enhanced CXCL10 production in response to IL-27. We conclude from our data that keratinocytes have a cell type-specific impaired capacity to up-regulate SOCS3 which may crucially determine the course of chronic inflammatory skin diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294695      PMCID: PMC3323061          DOI: 10.1074/jbc.M111.280370

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation.

Authors:  S Pflanz; I Kurth; J Grötzinger; P C Heinrich; G Müller-Newen
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

2.  Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment.

Authors:  Atsunobu Takeda; Shinjiro Hamano; Atsushi Yamanaka; Toshikatsu Hanada; Tatsuro Ishibashi; Tak W Mak; Akihiko Yoshimura; Hiroki Yoshida
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

3.  SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.

Authors:  J Schmitz; M Weissenbach; S Haan; P C Heinrich; F Schaper
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.

Authors:  Claudia Niemand; Ariane Nimmesgern; Serge Haan; Patrick Fischer; Fred Schaper; Rolf Rossaint; Peter C Heinrich; Gerhard Müller-Newen
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.

Authors:  Hua Xiong; Wan Du; Yan-Jie Zhang; Jie Hong; Wen-Yu Su; Jie-Ting Tang; Ying-Chao Wang; Rong Lu; Jing-Yuan Fang
Journal:  Mol Carcinog       Date:  2011-04-22       Impact factor: 4.784

6.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

7.  SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses.

Authors:  Yoh-ichi Seki; Hiromasa Inoue; Naoko Nagata; Katsuhiko Hayashi; Satoru Fukuyama; Koichiro Matsumoto; Okiru Komine; Shinjiro Hamano; Kunisuke Himeno; Kyoko Inagaki-Ohara; Nicholas Cacalano; Anne O'Garra; Tadahilo Oshida; Hirohisa Saito; James A Johnston; Akihiko Yoshimura; Masato Kubo
Journal:  Nat Med       Date:  2003-06-29       Impact factor: 53.440

8.  SOCS3 negatively regulates IL-6 signaling in vivo.

Authors:  Ben A Croker; Danielle L Krebs; Jian-Guo Zhang; Sam Wormald; Tracy A Willson; Edouard G Stanley; Lorraine Robb; Christopher J Greenhalgh; Irmgard Förster; Björn E Clausen; Nicos A Nicola; Donald Metcalf; Douglas J Hilton; Andrew W Roberts; Warren S Alexander
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

9.  SOCS3 regulates the plasticity of gp130 signaling.

Authors:  Roland Lang; Anne-Laure Pauleau; Evan Parganas; Yutaka Takahashi; Jörg Mages; James N Ihle; Robert Rutschman; Peter J Murray
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

10.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.

Authors:  Hideo Yasukawa; Masanobu Ohishi; Hiroyuki Mori; Masaaki Murakami; Takatoshi Chinen; Daisuke Aki; Toshikatsu Hanada; Kiyoshi Takeda; Shizuo Akira; Masahiko Hoshijima; Toshio Hirano; Kenneth R Chien; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-05-18       Impact factor: 25.606

View more
  6 in total

1.  Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling.

Authors:  Emilie Bourdonnay; Zbigniew Zasłona; Loka Raghu Kumar Penke; Jennifer M Speth; Daniel J Schneider; Sally Przybranowski; Joel A Swanson; Peter Mancuso; Christine M Freeman; Jeffrey L Curtis; Marc Peters-Golden
Journal:  J Exp Med       Date:  2015-04-06       Impact factor: 14.307

2.  IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

Authors:  A Visperas; J S Do; K Bulek; X Li; B Min
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

Review 3.  Extracellular Vesicles in Chronic Obstructive Pulmonary Disease.

Authors:  Tsukasa Kadota; Yu Fujita; Yusuke Yoshioka; Jun Araya; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  Int J Mol Sci       Date:  2016-10-27       Impact factor: 5.923

4.  Interleukin 6 Function in the Skin and Isolated Keratinocytes Is Modulated by Hyperglycemia.

Authors:  Eric G Lee; Lerin R Luckett-Chastain; Kaitlin N Calhoun; Benjamin Frempah; Anja Bastian; Randle M Gallucci
Journal:  J Immunol Res       Date:  2019-04-03       Impact factor: 4.818

5.  Histamine up-regulates oncostatin M expression in human M1 macrophages.

Authors:  Susanne Mommert; Marius Hüer; Katrin Schaper-Gerhardt; Ralf Gutzmer; Thomas Werfel
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

6.  Interleukin-27 controls basal pain threshold in physiological and pathological conditions.

Authors:  Tomoko Sasaguri; Toru Taguchi; Yuzo Murata; Kimiko Kobayashi; Sayaka Iizasa; Ei'ichi Iizasa; Makoto Tsuda; Naomi Hirakawa; Hiromitsu Hara; Hiroki Yoshida; Toshiharu Yasaka
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.